Skip to main content

Table 4 Comparison of the 3-year DFS rate of different treatment modalities in NT group and between NT group and CCRT group

From: MRI outcome evaluation in patients with IB2 and IIA2 squamous cervical cancer stages: preliminary results

Index Number 3-year DFS rate (%) p value
Neoadjuvant treatment    0.967
  NAC 31 84.0  
  NAR 28 82.0  
  NACR 27 78.0  
Adjuvant treatment    0.217
  Adjuvant treatment 38 73.0  
  Nonadjuvant treatment 48 88.0  
Adjuvant treatment    0.061
  ACT 7 100.0  
  ART 6 100.0  
  ACRT 25 60.0  
Treatment    0.863
  NT + RH 86 81.0  
  CCRT 63 80.0  
  1. NAC neoadjuvant chemotherapy; NAR neoadjuvant radiotherapy; NACR neoadjuvant chemoradiotherapy; ACT adjuvant chemotherapy; ART adjuvant radiotherapy; ACRT adjuvant chemoradiotherapy; NAT + RH neoadjuvant therapy followed by radical hysterectomy; CCRT concurrent chemoradiation